Palonosetron
FDA Approved: * November 21, 2017Pharm Company: * FRESENIUS KABI USA
Category: Cancer
Palonosetron, sold under the brand name Aloxi, is used for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).[1][3][4] It is a 5-HT3 antagonist.[1][3][4] Palonosetron is administered intravenously,[5] or as a single oral capsule.[6] It has a longer duration of action than other 5-HT3 antagonists. The oral formulation was approved on Aug... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Palonosetron Hydrochloride .25 mg/2ml Intravenous Injection
NDC: 0143-9513
Labeler:
West-ward Pharmaceuticals Corp
Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution
NDC: 0409-2504
Labeler:
Hospira, Inc.
Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution
NDC: 0703-4094
Labeler:
Teva Parenteral Medicines, Inc.
Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution
NDC: 0781-3312
Labeler:
Sandoz Inc
Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution
NDC: 0781-3415
Labeler:
Sandoz Inc
Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection
NDC: 16729-365
Labeler:
Accord Healthcare, Inc.
Palonosetron Hydrochloride .05 mg/ml Intravenous Injection
NDC: 23155-356
Labeler:
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution
NDC: 25021-783
Labeler:
Sagent Pharmaceuticals
Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution
NDC: 25021-788
Labeler:
Sagent Pharmaceuticals
Related Brands
Drugs with the same active ingredients